BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features
- PMID: 20950194
- DOI: 10.1089/thy.2009.0283
BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features
Abstract
Background: The cytological discrimination between benign and malignant follicular-patterned lesions of the thyroid can represent a diagnostic challenge, even for experienced pathologists. To attempt to clarify this diagnostic problem, we analyzed the BRAF status of thyroid tumors in a group of patients with follicular variant of papillary thyroid carcinoma (FVPTC) and its correlation with cytomorphological features.
Methods: The BRAF status was evaluated in a total of 187 patients in whom FVPTC was consecutively diagnosed by histology between January 2006 and January 2009. Each case had a previous fine-needle aspiration diagnosis classified according to the British Thyroid Association Guidelines categorized as inadequate (Thy1) (n = 19), benign (Thy2) (n = 19), follicular lesion and follicular lesion with atypia (Thy3) (n = 109), suspicious of PTC (Thy4) (n = 29), or malignant (Thy5) (n = 11). The first 68 cases were selected for a morphological study by a quantitative analysis of four cytological features (grooves, intranuclear cytoplasmatic inclusions, number of cells per high power field (400 ×), and mean nuclear diameter) of the carcinomas.
Results: The BRAF status of each tumor was correlated with the cytological classes. 54.5% and 27.6% of Thy5 and Thy4, respectively, were BRAF-mutated, against 12.1% of follicular lesions and 9.3% of follicular lesion with atypia (Thy3). This comparison was statistically significative (p = 0.0017). Among the 68 cases selected for the cyto-morphological study, the BRAF status frequency was similar to that of the total case series. No significant differences were found correlating the cytological classes with the number of cells, the number of grooves, and the mean cell diameters. Only the number of intranuclear cytoplasmatic inclusions were associated (p < 0.05) with the Thy5 cytological class.
Conclusions: BRAF is mutated in a low percentage of FVPTC, and most of these mutated cases are suspicious or positive on fine-needle aspiration. BRAF analysis is of limited value in the preoperative diagnosis of FVPTC.
Similar articles
-
Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.Cancer Cytopathol. 2015 Oct;123(10):593-602. doi: 10.1002/cncy.21586. Epub 2015 Jul 31. Cancer Cytopathol. 2015. PMID: 26230187
-
Follicular variant of papillary carcinoma: reproducibility of histologic diagnosis and utility of HBME-1 immunohistochemistry and BRAF mutational analysis as diagnostic adjuncts.Appl Immunohistochem Mol Morphol. 2010 May;18(3):231-5. doi: 10.1097/PAI.0b013e3181c61cdd. Appl Immunohistochem Mol Morphol. 2010. PMID: 20042852
-
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.Cancer Cytopathol. 2013 Apr;121(4):197-205. doi: 10.1002/cncy.21229. Epub 2012 Aug 7. Cancer Cytopathol. 2013. PMID: 22887810
-
From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.Ann Endocrinol (Paris). 2012 Jun;73(3):155-64. doi: 10.1016/j.ando.2012.03.002. Epub 2012 Apr 13. Ann Endocrinol (Paris). 2012. PMID: 22503804 Review.
-
Risk stratification in follicular neoplasm: a cytological assessment using the modified Bethesda classification.Cancer Cytopathol. 2014 Jul;122(7):536-45. doi: 10.1002/cncy.21425. Epub 2014 Apr 18. Cancer Cytopathol. 2014. PMID: 24753500 Review.
Cited by
-
Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of RAS mutation testing.Thyroid. 2013 Nov;23(11):1416-22. doi: 10.1089/thy.2012.0640. Epub 2013 Jul 25. Thyroid. 2013. PMID: 23590130 Free PMC article.
-
The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis.Endocrine. 2014 Apr;45(3):462-8. doi: 10.1007/s12020-013-0029-5. Epub 2013 Aug 8. Endocrine. 2014. PMID: 23925579
-
Subclassification of the "grey zone" of thyroid cytology; a retrospective descriptive study with clinical, cytological, and histological correlation.J Thyroid Res. 2011;2011:251680. doi: 10.4061/2011/251680. Epub 2011 Jun 16. J Thyroid Res. 2011. PMID: 21760976 Free PMC article.
-
BRAF(V600E) mutation analysis from May-Grünwald Giemsa-stained cytological samples as an adjunct in identification of high-risk papillary thyroid carcinoma.Endocr Pathol. 2011 Dec;22(4):195-9. doi: 10.1007/s12022-011-9180-9. Endocr Pathol. 2011. PMID: 21948220
-
The follicular variant of papillary thyroid carcinoma: characteristics of preoperative ultrasonography and cytology.Ultrasonography. 2016 Jan;35(1):47-54. doi: 10.14366/usg.15037. Epub 2015 Jul 24. Ultrasonography. 2016. PMID: 26299354 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous